S. X. Huang, M. C. Jaurand, D. W. Kamp, J. Whysner, and T. K. Hei, Role of mutagenicity in asbestos fiberinduced carcinogenicity and other diseases, J Toxicol Environ Health B Crit Rev, vol.14, pp.179-245, 2011.

B. Jasani and A. Gibbs, Mesothelioma not associated with asbestos exposure, Arch Pathol Lab Med, vol.136, pp.262-267, 2012.

J. R. Testa, M. Cheung, P. J. Below, J. E. Tan, Y. Sementino et al., Germline BAP1 mutations predispose to malignant mesothelioma, Nat Genet, vol.43, pp.1022-1025, 2011.

D. Jean, J. Daubriac, L. Pimpec-barthes, F. Galateau-salle, F. et al., Molecular changes in mesothelioma with an impact on prognosis and treatment, Arch Pathol Lab Med, vol.136, pp.277-293, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02478588

M. Bott, M. Brevet, B. S. Taylor, S. Shimizu, T. Ito et al., The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma, Nat Genet, vol.43, pp.668-672, 2011.

A. J. Cesare and R. R. Reddel, Alternative lengthening of telomeres: models, mechanisms and implications, Nat Rev Genet, vol.11, pp.319-330, 2010.

R. Villa, M. G. Daidone, R. Motta, L. Venturini, D. Marco et al., Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma, Clin Cancer Res, vol.14, pp.4134-4140, 2008.

A. Y. Au, T. Hackl, T. R. Yeager, S. B. Cohen, H. I. Pass et al., Telomerase activity in pleural malignant mesotheliomas, Lung Cancer, vol.73, pp.283-288, 2011.

K. Dhaene, R. Hubner, S. Kumar-singh, B. Weyn, and E. Van-marck, Telomerase activity in human pleural mesothelioma, Thorax, vol.53, pp.915-918, 1998.

F. Kumaki, T. Kawai, A. Churg, F. B. Galateau-salle, P. Hasleton et al., Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas, Am J Surg Pathol, vol.26, pp.365-370, 2002.

M. Gladych, A. Wojtyla, and B. Rubis, Human telomerase expression regulation, Biochem Cell Biol, vol.89, pp.359-376, 2011.

S. Horn, A. Figl, P. S. Rachakonda, C. Fischer, A. Sucker et al., TERT promoter mutations in familial and sporadic melanoma, Science, vol.339, pp.959-961, 2013.

F. W. Huang, E. Hodis, M. J. Xu, G. V. Kryukov, L. Chin et al., Highly recurrent TERT promoter mutations in human melanoma, Science, vol.339, pp.957-959, 2013.

P. J. Killela, Z. J. Reitman, Y. Jiao, C. Bettegowda, N. Agrawal et al., TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal, Proc Natl Acad Sci U S A, vol.110, pp.6021-6026, 2013.

L. Zeng, A. Buard, I. Monnet, C. Boutin, J. Fleury et al., In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines, Int J Cancer, vol.55, pp.515-520, 1993.

D. Jean, E. Thomas, M. E. Renier, A. De-reynies, A. Lecomte et al., Syntenic Relationships between Genomic Profiles of Fiber-Induced Murine and Human Malignant Mesothelioma, Am J Pathol, vol.178, pp.881-894, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00531343

A. N. Husain, T. V. Colby, N. G. Ordonez, T. Krausz, A. Borczuk et al., Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group, Arch Pathol Lab Med, vol.133, pp.1317-1331, 2009.

Y. Cao, T. M. Bryan, and R. R. Reddel, Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells, Cancer Sci, vol.99, pp.1092-1099, 2008.

M. Daniel, G. W. Peek, and T. O. Tollefsbol, Regulation of the human catalytic subunit of telomerase (hTERT), Gene, vol.498, pp.135-146, 2012.

M. Ramael, J. Van-den-bossche, C. Buysse, I. Deblier, K. Segers et al., Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura, Histol Histopathol, vol.10, pp.639-643, 1995.

N. S. Wang, The Pleura in Health and Disease, pp.23-42, 1985.

S. E. Mutsaers, Mesothelial cells: their structure, function and role in serosal repair, Respirology, vol.7, pp.171-191, 2002.

X. H. Shen, S. J. Xu, C. Y. Jin, F. Ding, Y. C. Zhou et al., Interleukin-8 prevents oxidative stress-induced human endothelial cell senescence via telomerase activation, Int Immunopharmacol, vol.16, pp.261-267, 2013.

N. J. Ganem and D. Pellman, Linking abnormal mitosis to the acquisition of DNA damage, J Cell Biol, vol.199, pp.871-881, 2012.

C. Lecomte, P. Andujar, A. Renier, L. Kheuang, V. Abramowski et al., Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma, Cell Cycle, vol.4, pp.1862-1869, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01928388

P. Andujar, J. Wang, A. Descatha, F. Galateau-salle, I. Abd-alsamad et al., p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos, Lung Cancer, vol.67, pp.23-30, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00388198

P. Andujar, J. C. Pairon, A. Renier, A. Descatha, I. Hysi et al., Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma, Mutagenesis, vol.28, pp.321-323, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02478590

L. G. Larsson, Oncogene-and tumor suppressor gene-mediated suppression of cellular senescence, Semin Cancer Biol, vol.21, pp.367-376, 2011.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2012.

A. V. Bazarov, M. Van-sluis, W. C. Hines, E. Bassett, A. Beliveau et al., p16(INK4a) -mediated suppression of telomerase in normal and malignant human breast cells, Aging Cell, vol.9, pp.736-746, 2010.